Implementing tNGS for Detection of Drug-Resistant TB in High Burden Countries
A webinar series organized by the Stop TB Partnership and FIND
This webinar series will familarize participants with the recently published WHO recommendations on the use of tNGSt to detect TB drug resistance and help guide clinical decision-making, adoption considerations, available resources for implmentations, and the status of current efforts to improve assay performance. Early implementing high burden countries will share their experiences using tNGS including for clinical decision-making, and manufacturers of tNGS assays will be invited to share information on their products.
World Patient Safety Day calls for global solidarity and concerted action by all countries and international partners to improve patient safety.
The Day brings together patients, families, caregivers, communities, health workers, health care leaders and policy-makers to show their commitment to patient safety.
The resolution WHA 72.6 ‘Global action on patient safety’ recognizes patient safety as a global health priority and endorses the establishment of World Patient Safety Day to be observed annually on 17 September.
Date: 24 September 2024 Time:8:00-10:00 AM (EDT) Location:New York City.
The TB Vaccines Dialogue will convene relevent key country and global stakeholders and partners who, now and in the future, will be actively and concretely engaged in the practical and realistic development and delivery of TB vaccines.
The event will catalyze the necessary discussion to understand and start addressing critical misconceptions, questions, and knowledge gaps, including needs, desires, and challenges related to the practical and realistic development and delivery of TB vaccines.
For more information about the TB Vaccines Dialogue, please email the External Affairs & Strategic Initiatives team at EASI@stoptb.org.
Date: 24 September, 2024 Time: 5.30-7.30 PM, Eastern Time Location:Westin Grand Central, New York Livestream: Stop TB Partnership YouTube and Facebook
As the UN member states prepare to convene and vote on the final draft of the Political Declaration on AMR during the UN-HLM on AMR on 26th September, the Stop TB Partnership is using this critical moment to bring together global health leaders from the governments, donors, civil society, researchers and academia to identify the priority actions needed to put the world on track to end TB and AMR, and outline how the AMR and TB communities can work together from the global to the local level to advance action.
The event will also focus on increasing the understanding among leaders, policymakers and stakeholders about the need for increasing investments and collaboration on AMR and DR-TB research and implementation. It also aims to demonstrate the TB community’s leadership in the fight against AMR by bringing the TB and AMR community together to discuss alignment, areas for increased collaboration, and how the TB response can advance action on AMR.
The registrations for the event are now closed but if you wish to attend this event in-person, please contact communications@stoptb.org
Date: 25 September, 2024 Time: 7.00-9.00 AM, Eastern Time Location:Sofitel, New York Livestream:Stop TB Partnership YouTube and Zoom
USAID and Stop TB Partnership will launch a new report on the governance of TB responses in 21 countries. This report presents benchmarks for good governance in four thematic areas and assesses TB responses in high burden countries against these benchmarks.
National TB programs as well as in-country civil society partners have contributed data for this report. At this launch event the contents of the report will be presented along with perspectives from USAID, Stop TB Partnership and Civil Society.
The meeting is being held in a hybrid format. In-person meeting is by invitation only. We welcome you to join virtually for which you can register here. It can also be watched live on YouTube.
UN General Assembly High-Level Meeting on antimicrobial resistance 2024
The UN General Assembly will convene a High-Level Meeting on antimicrobial resistance (AMR) for the second time during its 79th session (UNGA 79) in New York in September 2024. Drug-resistant infections know no borders, meaning no single country can respond to AMR alone. This meeting is an important opportunity for world leaders to collectively address the looming threat AMR poses to global health, food security, and achieving the 2030 Sustainable Development Goals.
Organized by the President of the General Assembly, a multi-stakeholder hearing on AMR took place on 15 May 2024, as part of the preparatory process for the High-level Meeting. The hearing was a key moment for stakeholders from across different sectors to contribute, ahead of intergovernmental negotiations on the political declaration. The hearing was supported by WHO, the Food and Agriculture Organization of the United Nations, the United Nations Environment Programme, the World Organisation for Animal Health (also known collectively as the Quadripartite organizations) and other relevant partners.
The Stop TB Partnership will host three side events on the sidelines of the United Nations High-Level Meeting (HLM) on antimicrobial resistance (AMR), and offer platforms to discuss the progress, achievements and challenges against the targets set in 2023 TB Political Declaration while creating insightful discussions on how fighting AMR will accelerate the fight against TB.
A strong delegation of TB and drug-resistant TB survivors and civil society will lead and join these events.
The side events are being organized on 24th and 25th September 2024 and co-hosted with the United States Agency for International Development (USAID), Japan’s Ministry of Health, Labour and Welfare, Indonesia’s Ministry of Health, Philippines Department of Health and Tajikistan’s Ministry of Health and Social Protection of Population.
While all three are in-person events, Stop TB Partnership will livestream two events on its official YouTube and Facebook channels. A complete list of all the events is below.
Ending TB by 2030 is possible with the right strategies and funding.
